The primary objective of the VACOLUP study was to assess the tolerance of COVID-19 vaccines, including risk for incident flares, in patients with systemic lupus erythematosus.
Researchers assessed the risk for hyperinflammation and respiratory failure among hospitalized patients with COVID-19 and a systemic rheumatic disease.
This case-series described the effect of the COVID-19 pandemic on the incidence of movement disorders in children and adults.
This case series described the different reports of CVST with thrombocytopenia following receipt of the Johnson & Johnson COVID-19 vaccine.
The immunogenicity and safety of SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions receiving immunosuppressive therapy were determined.
This review of current literature discusses emerging therapies directed at COPD endotypes and pathobiological processes that manifest as the disease.
Chronic obstructive pulmonary disease (COPD) continues to be a major cause of disability and is one of the leading causes of mortality worldwide. Here, we summarize COPD pathology, available treatment options and additional potential pathways and targets for new therapeutic development.
Neuropathological changes in patients with coronavirus disease 2019 are relatively mild, with neuroinflammatory changes in the brain stem most often found.
Researchers analyzed the association of asthma and its subgroups with osteoporosis in the Korean adult population, and determined the effects of asthma on osteoporosis based on condition of asthma management.
Antiplatelet therapy may delay progression of COPD, decrease the risk for acute exacerbations, improve quality of life, and even reduce all-cause mortality.
